140 related articles for article (PubMed ID: 24887387)
1. Caregivers' quality of life after blood and marrow transplantation: a qualitative study.
Jim HS; Quinn GP; Barata A; Cases M; Cessna J; Gonzalez B; Gonzalez L; Koskan A; Montiel-Ishino F; Pidala J
Bone Marrow Transplant; 2014 Sep; 49(9):1234-6. PubMed ID: 24887387
[No Abstract] [Full Text] [Related]
2. Irradiated blood components.
Benson K; Elfenbein G
Am J Clin Pathol; 1997 Feb; 107(2):251; author reply 253-4. PubMed ID: 9024077
[No Abstract] [Full Text] [Related]
3. Impact of a health information technology tool addressing information needs of caregivers of adult and pediatric hematopoietic stem cell transplantation patients.
Fauer AJ; Hoodin F; Lalonde L; Errickson J; Runaas L; Churay T; Seyedsalehi S; Warfield C; Chappell G; Brookshire K; Chaar D; Shin JY; Byrd M; Magenau J; Hanauer DA; Choi SW
Support Care Cancer; 2019 Jun; 27(6):2103-2112. PubMed ID: 30232587
[TBL] [Abstract][Full Text] [Related]
4. Haploidentical stem cell transplantation-bone marrow vs peripheral blood.
Gulbas Z
Transfus Apher Sci; 2018 Apr; 57(2):168-170. PubMed ID: 29764770
[TBL] [Abstract][Full Text] [Related]
5. 'The Mexican approach' to conduct NST.
Ruiz-Argüelles GJ
Eur J Haematol; 2001; 67(5-6):335. PubMed ID: 11872085
[No Abstract] [Full Text] [Related]
6. Unrelated bone marrow transplantation using a reduced intensity-conditioning regimen in leukocyte adhesion deficiency.
Takahashi D; Nagatoshi Y; Saito Y; Inagaki J; Nagayama J; Shinkoda Y; Fujita K; Okamura J
Bone Marrow Transplant; 2006 Apr; 37(8):807-8. PubMed ID: 16532019
[No Abstract] [Full Text] [Related]
7. [Bone marrow transplantation in the treatment of autoimmune disease].
Farge D
Rev Med Interne; 2007 Dec; 28 Suppl 4():S285-7. PubMed ID: 17980463
[No Abstract] [Full Text] [Related]
8. Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics.
Keklik F; Alrawi EB; Cao Q; Bejanyan N; Rashidi A; Lazaryan A; Arndt P; Dincer EH; Bachanova V; Warlick ED; MacMillan ML; Arora M; Miller J; Brunstein CG; Weisdorf DJ; Ustun C
Haematologica; 2018 Dec; 103(12):2109-2115. PubMed ID: 30076172
[TBL] [Abstract][Full Text] [Related]
9. [Allogeneic transplantation of stem cells].
Einsele H; Kanz L
Internist (Berl); 1999 Dec; 40(12):1249-56. PubMed ID: 10642911
[No Abstract] [Full Text] [Related]
10. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts.
Brunstein CG; Fuchs EJ; Carter SL; Karanes C; Costa LJ; Wu J; Devine SM; Wingard JR; Aljitawi OS; Cutler CS; Jagasia MH; Ballen KK; Eapen M; O'Donnell PV;
Blood; 2011 Jul; 118(2):282-8. PubMed ID: 21527516
[TBL] [Abstract][Full Text] [Related]
11. Thirty Years of Bone Marrow Transplantation in the Singapore General Hospital.
Phipps C; Ho AY; Linn YC; Gopalakrishnan S; Ang AL; Lee JJ; Ng HY; Lim FW; Goh PS; Loh YS; Tan PH; Koh LP; Koh MB; Lee LH; Goh YT; Ong YW; Hwang WY
Ann Acad Med Singap; 2016 Jul; 45(7):315-7. PubMed ID: 27523512
[No Abstract] [Full Text] [Related]
12. Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study.
Sengsayadeth S; Labopin M; Boumendil A; Finke J; Ganser A; Stelljes M; Ehninger G; Beelen D; Niederwieser D; Blaise D; Dreger P; Mufti G; Chevallier P; Mailhol A; Gatwood KS; Gorin N; Esteve J; Ciceri F; Baron F; Schmid C; Giebel S; Mohty M; Savani BN; Nagler A
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1406-1414. PubMed ID: 29678639
[TBL] [Abstract][Full Text] [Related]
13. Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation.
Novotny JR; Rosenthal C; Elmaagacli AH; Dürig J; Beelen DW; Dührsen U
Eur J Haematol; 2004 Jul; 73(1):1-9. PubMed ID: 15182331
[TBL] [Abstract][Full Text] [Related]
14. Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantation.
Mohty M; Duarte RF; Kuball J; Bader P; Basak GW; Bonini C; Carreras E; Chabannon C; Dufour C; Gennery A; Lankester A; Lanza F; Ljungman P; Montoto S; Nagler A; Snowden JA; Styczynski J; Sureda A; Kröger N
Bone Marrow Transplant; 2018 Dec; 53(12):1548-1552. PubMed ID: 29720705
[TBL] [Abstract][Full Text] [Related]
15. An unconditioned bone marrow transplantation in a child with purine nucleoside phosphorylase deficiency and its unique complication.
Aytekin C; Yuksek M; Dogu F; Yagmurlu A; Yildiran A; Fitoz S; Kologlu M; Babacan E; Hershfield MS; Ikinciogullari A
Pediatr Transplant; 2008 Jun; 12(4):479-82. PubMed ID: 18208442
[TBL] [Abstract][Full Text] [Related]
16. Management of Myelodysplastic Syndrome Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: A Study by the French Society of Bone Marrow Transplantation and Cell Therapies.
Guièze R; Damaj G; Pereira B; Robin M; Chevallier P; Michallet M; Vigouroux S; Beguin Y; Blaise D; El Cheikh J; Roos-Weil D; Thiebaut A; Rohrlich PS; Huynh A; Cornillon J; Contentin N; Suarez F; Lioure B; Mohty M; Maillard N; Clement L; François S; Guillerm G; Yakoub-Agha I
Biol Blood Marrow Transplant; 2016 Feb; 22(2):240-247. PubMed ID: 26256942
[TBL] [Abstract][Full Text] [Related]
17. Nonmyeloablative bone marrow transplants.
Olszewski S
Clin J Oncol Nurs; 2003; 7(6):675-6. PubMed ID: 14705484
[No Abstract] [Full Text] [Related]
18. Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Multiple Myeloma.
Ghosh N; Ye X; Tsai HL; Bolaños-Meade J; Fuchs EJ; Luznik L; Swinnen LJ; Gladstone DE; Ambinder RF; Varadhan R; Shanbhag S; Brodsky RA; Borrello IM; Jones RJ; Matsui W; Huff CA
Biol Blood Marrow Transplant; 2017 Nov; 23(11):1903-1909. PubMed ID: 28711728
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood versus bone marrow transplant in patients with aplastic anemia, an unresolved issue.
Ghavamzadeh A; Alimoghaddam K; Jalili M; Mousavi SA; Bahar B; Kasaeian A; Hamidieh AA; Behfar M; Vaezi M; Jalali A; Jahani M
Bone Marrow Transplant; 2016 Dec; 51(12):1628-1630. PubMed ID: 27668763
[No Abstract] [Full Text] [Related]
20. Assessment of immune reconstitution status in recipients of a successful hematopoietic stem cell transplant from peripheral blood after reduced intensity conditioning.
Jaime-Pérez JC; Villarreal-Villarreal CD; Méndez-Ramírez N; Vázquez-Garza E; Salazar-Riojas R; Gómez-Almaguer D
Blood Cells Mol Dis; 2016 May; 58():52-6. PubMed ID: 27067489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
